Invetech Videos

  1. Why iPSC Is Research Thriving 5/23/2025

    In this first segment of Cell & Gene Live, Unlocking the Potential of iPSC Therapies in Regenerative Medicine, Julie Allickson, Ph.D., Chief Technology Officer at Mayo Clinic's Center for Regenerative Biotherapeutics and Erin Kimbrel, Ph.D., Head of Cell & Gene Therapy Research at Astellas highlight the transformative potential of regenerative medicine and iPSC-based therapies. They emphasize the versatility and scalability of pluripotent stem cells, particularly for allogeneic applications that could eliminate the need for immunosuppression. These advances hold promise for treating complex diseases like diabetes, multiple sclerosis, and cardiac conditions, with the goal of making therapies more accessible and impactful on a global scale.

  2. Invetech Cell & Gene Tech Expo April 2025: Cell Therapy 4/28/2025

    Explore a collaborative approach in diagnostics and cell therapy applications that has successfully addressed manufacturing challenges to enable scalable automation solutions from early-stage development to end-to-end processes.

  3. Revolutionizing Cell Therapy Manufacturing With AI 11/7/2024

    Discover how AI can optimize processes, improve efficiency, and enhance the understanding of cellular processes, ultimately leading to more effective and personalized patient treatments.

  4. Invetech Bio-Expo Live 2024: Downstream Bioprocessing 8/14/2024

    With the demand for specialized equipment that can effectively meet evolving needs, learn about innovative solutions and gain insights into incorporating scalability from the early stages of equipment development.

  5. Inside Next-Gen Platforms For Cell Therapy Manufacturing | Audience Q&A 7/3/2024

    In one of our most active Cell & Gene Live audience Q&As to date, Will Junker and Nick Siciliano responded to several audience questions ranging in scope from reducing environmental control requirements with respect to total COGs for cell therapy manufacturing to the technologies that benefit in closing of processes.

  6. How To Develop And Maintain A Scalable Cell Therapy Manufacturing Process 7/3/2024

    In this segment, Will Junker and Nick Siciliano share their expertise on how venture capital, driving clinical trials, and clear path to commercialization all help to achieve scalability.

  7. The Importance of Advanced Analytics in Cell Therapy Manufacturing 7/3/2024

    In this segment, expert panelists explain the advanced analytics and process monitoring technologies utilized in cell therapy manufacturing and how they help improve process control and product quality.

  8. The Primary Benefits Of Closed-System Manufacturing 7/3/2024

    Experts explain the primary benefits of closed-system manufacturing for cell therapies, particularly in terms of product quality, safety, and regulatory compliance, during this Cell & Gene Live Event.

  9. The Future Of Automation & Robotics In Cell Therapy Manufacturing 7/3/2024

    Expert panelists on the Cell & Gene Live event discuss the tasks and processes currently automated in the cell & gene therapy space, as well as how automation technologies impact job roles and skill requirements.

  10. The Current State Of Cell Therapy Manufacturing 7/3/2024

    Expert panelists on Cell & Gene Live, Inside Next-Gen Platforms for Cell Therapy Manufacturing, share their points of view on cell therapy manufacturing as it stands today.